|

Effect of Multimodal Exercise Training in Patients With Multiple Sclerosis

RECRUITINGN/ASponsored by Istanbul University - Cerrahpasa
Actively Recruiting
PhaseN/A
SponsorIstanbul University - Cerrahpasa
Started2025-02-10
Est. completion2027-05-01
Eligibility
Age20 Years – 65 Years
Healthy vol.Accepted

Summary

The study aims to examine the effects of multimodal exercise training including aerobic, strengthening and balance exercises via face-to-face and asynchronous video-based telerehabilitation on disease activity, disability level, aerobic capacity, physical activity level, balance, fatigue level and quality of life in individuals with multiple sclerosis. Therefore, this study consists of two hypotheses. Hypotheses: H0: Multimodal exercise training has no effect on disease activity and functional status in patients with multiple sclerosis H1: Multimodal exercise training has effects on disease activity and functional status in patients with multiple sclerosis

Eligibility

Age: 20 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Being diagnosed with multiple sclerosis by a neurologist
* Volunteering to participate in the study
* Being ambulatory
* EDSS between 3.0-5.5
* Being literate
* Having internet access
* Not having participated in a standardized physiotherapy and rehabilitation program in the last 3 months

Exclusion Criteria:

* Having an orthopedic problem affecting its mobility
* Having psychiatric problems, severe cognitive impairment, or epilepsy in addition to the MS diagnosis
* Blurred vision or visual impairment
* Pregnancy
* Having had an attack or received corticosteroid treatment 3 months before participating in the study
* Having a disease affecting immunological parameters (infection, cancer, etc.)

Conditions1

Multiple Sclerosis

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.